Drug Research
Antibody Drug Conjugates: Future Therapies And Treatment
Beyond cancer, there are a number of sectors that provide considerable prospects for antibody drug conjugates (ADCs), using their capacity to deliver therapeutic drugs selectively to sick cells or tissues while avoiding off-target effects. These opportunities may be used...
Drug Research
Advancements In ADCs: Important Trends And Market Insights
Antibody drug conjugates (ADCs) are the main players in the fields of cancer clinical research and deal-making, with new alliances and contracts appearing on a regular basis. Businesses set themselves apart as the ADC market grows increasingly saturated by...
Drug Research
AI In Pharma: Speeding Up Drug Discovery And Innovation
The world is very interested in generative artificial intelligence (GAI), and for good reason. People have a better idea of what AI can do thanks to platforms like ChatGPT that have shown what it can do. AI is also...
Drug Research
FDA Workshop On AI In Drug Development: The Key Takeaways
A full-day training called Artificial Intelligence in Drug and Biological Product Development was held on August 6, 2024, by the Food and Drug Administration (FDA) and the Clinical Trials Transformation Initiative (CTTI). There were four panels at the workshop,...
Drug Research
Future of Cell And Gene Therapy: Overcoming Growth Hurdles
It is not always easy to go from novel research to a working business plan. There are still problems with prices and safety, as well as legal issues that make it hard to make cell and gene treatments on...
Drug Research
Rising Cell & Gene Therapy Market: Trends And Technology
In 2023, the market for cell and gene therapy was worth USD 18.8 billion. In the years to come, the market is projected to grow at a rate of 15.66% per year, reaching USD 60.1 Billion by 2032.
Regulatory changes,...
Drug Research
The Inroads and Issues In Gene Therapy Manufacturing Realm
Cell and gene treatments are now one of the pharmaceutical industry's fastest-growing segments, with more and more being investigated for a variety of purposes.
The US Food and Drug Administration (FDA) approved Casgevy, the first CRISPR-based gene therapy, at the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.